News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...

A new global study warns that chronic kidney disease is quietly becoming a major public health crisis, with cases worldwide ...

A new analysis from the Global Burden of Disease Study published in The Lancet in November 20251, shows that the impact of ...

MeiraGTx Holdings has signed a deal with Eli Lilly , potentially worth over $475 million, granting the pharma giant rights to ...

Record numbers of men and women globally are now estimated to have reduced kidney function, a new study shows. Figures rose from 378 million people with the disease in 1990 to 788 million in 2023 as ...

Exposure to endocrine-disrupting bisphenol chemicals—including bisphenol A (BPA), bisphenol S (BPS), and bisphenol F (BPF)—was associated with more than 127 million cases of obesity, type 2 diabetes ...

It also took the spot as the 12th leading cause of disability-adjusted life-years (DALYs), with an age-standardized DALY rate ...

Cutting-edge nanotech reduced beta-amyloid from Alzheimer's disease by 45% in a matter of hours, representing a key breakthrough.

Rising chronic kidney disease prevalence and morbidity rates in 2023 make CKD the ninth leading cause of death globally, ...

A director at American Addiction Centers lays out the reasons, and many ways, for employers to become a recovery-friendly ...

CKD now affects 788 million adults globally, killing 1.48 million each year—linked to diabetes, hypertension, and ageing ...